Literature DB >> 18323671

Identification of genes differentially expressed in mouse fetuses from streptozotocin-induced diabetic pregnancy by cDNA subtraction.

Nanako Sato1, Yoshihisa Sugimura, Yoshitaka Hayashi, Takashi Murase, Yasuhiko Kanou, Fumitaka Kikkawa, Yoshiharu Murata.   

Abstract

Epidemiological studies have shown that the risks of fetal malformation such as neural tube defects increase in diabetic pregnancy. To explore the mechanism of fetal malformation induced by diabetes, cDNA subtraction using mouse embryos (E9.5) of diabetic dams and those of controls was performed to identify differentially expressed genes. The expression level of genes identified by cDNA subtraction was further verified by quantitative RT-PCR using E8.5 embryos, and differential expression of 4 genes, Brcc3, Commd3, Ddx1, and SET was confirmed. We also analyzed the expression level of neural tube defect-related genes, and found that Folbp1, EphrinA5 and Sox10 were differentially expressed. Altered expression of these genes mostly persisted throughout the later stages of the development (E10.5-14.5). Hierarchical clustering analysis showed correlation between expression levels of these genes, suggesting that these genes cooperatively play a role in embryonic development. Our results suggest that an altered gene expression profile in embryos underlies the development of congenital malformation in diabetic pregnancies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18323671     DOI: 10.1507/endocrj.k07-117

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  3 in total

Review 1.  Understanding diabetic teratogenesis: where are we now and where are we going?

Authors:  Sheller Zabihi; Mary R Loeken
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-10

2.  Identification of histone malonylation in the human fetal brain and implications for diabetes-induced neural tube defects.

Authors:  Qin Zhang; Tanxi Cai; Zonghui Xiao; Dan Li; Chunlei Wan; Xiaodai Cui; Baoling Bai
Journal:  Mol Genet Genomic Med       Date:  2020-07-15       Impact factor: 2.183

Review 3.  The status of diabetic embryopathy.

Authors:  Ulf J Eriksson; Parri Wentzel
Journal:  Ups J Med Sci       Date:  2016-04-27       Impact factor: 2.384

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.